Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Levy, R.
Right arrow Articles by Ménézo, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, R.
Right arrow Articles by Ménézo, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update, Vol.10, No.3 pp.241-250, 2004
© European Society of Human Reproduction and Embryology 2004; all rights reserved

Cytoplasmic transfer in oocytes: biochemical aspects

Rachel Levy1,4, Kay Elder2 and Yves Ménézo3

1 Laboratoire de Biologie de la Reproduction, Hôpital Nord, 42055 Saint Etienne, France, 2 Bourn Hall Clinic, Bourn, Cambridge CB3 7TR, UK and 3 IRH–Laboratoire Marcel Mérieux, 1 rue Laborde, 69500 BRON, France 4 To whom correspondence should be addressed. e-mail: rachel.levy{at}chu-st-etienne.fr

Cytoplasmic control of preimplantation development is not a ‘new’ concept; the first cytoplasmic transfer experiment was performed in the mouse during the early 1980s, as a means of overcoming cleavage arrest at the 2-cell stage, the ‘2-cell block’. Since the first human pregnancy following the transfer of cytoplasm from donor oocytes into the oocytes of a patient with a history of poor embryo development and recurrent implantation failure in 1997, >30 children have been born after direct injection of ooplasm from fresh, mature or immature, or cryopreserved–thawed donor oocytes into recipient oocytes via a modified ICSI technique. Transfer of ooplasm was thus applied with astonishing speed in humans, in the absence of extensive research to evaluate the efficacy and the possible risks of the method. This review focuses on biochemical mechanisms by which transfer of ooplasm might confer a benefit: by correcting a putative imbalance between anti- and pro-apoptotic factors and/or correction of defective mitochondrial membrane potential. We also emphasize the ‘empirical’ state of this technique, and the related risks.

Key words: apoptosis/epigenetic risk/ooplasm transfer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
S. M. Khan, R. M. Smigrodzki, and R. H. Swerdlow
Cell and animal models of mtDNA biology: progress and prospects
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C658 - C669.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. A. Lobo
Potential Options for Preservation of Fertility in Women
N. Engl. J. Med., July 7, 2005; 353(1): 64 - 73.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.